Health and Healthcare

ImmunoGen : IMGN

All IMGN Articles

66 Articles

Chris Lange | May 12, 2016

ASCO Could Make or Break These 7 Cancer Drug Trials

The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society…

Paul Ausick | May 2, 2016

The 52-Week Low Club for Monday

May 2, 2016: Here are four stocks trading with relatively heavy volume among 24 equities making new 52-week lows in…

Paul Ausick | Apr 29, 2016

The 52-Week Low Club for Friday

April 29, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in…

Lee Jackson | Dec 2, 2015

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

A new Jefferies research report focuses on some biotech and specialty pharmaceutical stocks that have had some headline and clinical…

Jon C. Ogg | Nov 25, 2015

Top Analyst Upgrades and Downgrades: AmEx, Carnival, eBay, HP, IAMGOLD, Pfizer, Tech Data and Many More

Stocks were indicated surprisingly higher after international markets recovered more than might have been expected. The trend that has been…

Jon C. Ogg | Aug 3, 2015

Top Analyst Upgrades and Downgrades: Arch Coal, Autodesk, CarMax, Coach, ExxonMobil, Disney, Whiting and More

Monday's top analyst upgrades downgrades and initiations include Arch Coal, Autodesk, CarMax, Coach, Exxon Mobil, Walt Disney and Whiting Petroleum.

Chris Lange | Jun 7, 2015

How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer

24/7 Wall St. has taken a look at some of the major ASCO winners over the past week and how…

Chris Lange | Jun 1, 2015

6 Key Cancer Winners From ASCO Presentations

24/7 Wall St. has taken a look at a few of the major ASCO winners so far. Color and background…

Chris Lange | May 14, 2015

The 5 Winners and Losers From ASCO Presentations

Investors, doctors and cancer patients are anxiously awaiting some of the key presentations and abstracts from the American Society of…

Jon C. Ogg | Feb 7, 2015

5 Analyst Stock Picks Under $10 With Massive Upside Projections

Here are this past week's five analyst picks under $10 with colossal upside featured by 24/7 Wall St.

Jon C. Ogg | Dec 27, 2014

13 Analyst Stocks at $10 and Under With Huge Implied Upside

Many investors are looking for where to put their money now that the Dow Jones Industrial Average has hit 18,000.

Paul Ausick | Dec 19, 2014

The 52-Week Low Club for Friday

ThinkstockDecember 19, 2014: Here are four stocks among the 55 equities making new 52-week lows today. Ascena Retail Group Inc.…

Lee Jackson | Sep 3, 2014

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

A Cowen report zeroes in on the most illiquid stocks that will be traded Wednesday as 15 ETFs rebalance.

Jon C. Ogg | Jun 25, 2014

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, June 25, 2014. They include Apple, Coach,…

Jon C. Ogg | Jun 12, 2014

Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 12, 2014. They include Apache, Apple,…

1 2 3 4 5

Our $500K AI Portfolio

See us invest in our favorite AI stock ideas for free

Our Investment Portfolio

NVIDIA Shares Dropped 7% This Week: 3 Catalysts For the Fall

Live

Eric Bleeker |

Nov 9, 2025

NVIDIA Shares Dropped 7% This Week: 3 Catalysts For the Fall

Live

Eric Bleeker |

Nov 4, 2025

ImmunoGen : IMGN

All IMGN Articles

ASCO Could Make or Break These 7 Cancer Drug Trials

The 52-Week Low Club for Monday

The 52-Week Low Club for Friday

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

Top Analyst Upgrades and Downgrades: AmEx, Carnival, eBay, HP, IAMGOLD, Pfizer, Tech Data and Many More

Top Analyst Upgrades and Downgrades: Arch Coal, Autodesk, CarMax, Coach, ExxonMobil, Disney, Whiting and More

How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer

6 Key Cancer Winners From ASCO Presentations

The 5 Winners and Losers From ASCO Presentations

5 Analyst Stock Picks Under $10 With Massive Upside Projections

13 Analyst Stocks at $10 and Under With Huge Implied Upside

The 52-Week Low Club for Friday

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More

Will The Age When You Claim Social Security Affect Your Future COLA?

President Trump Wants to Send a Stimulus Check. How Much Will You Get?

Even Cisco’s 2% Dividend Can’t Save Them From Investor Hate

Our $500K AI Portfolio

NVIDIA Shares Dropped 7% This Week: 3 Catalysts For the Fall

Live: Will AMD Blow Out Q3 Earnings Tonight?